自贡招聘

职位描述：

About the department

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Discovery Technology China (DTC) is a fully integrated part of the Global Research (GR) of Novo Nordisk R&D and unit of excellence in turning proteins into valuable pharmaceuticals and developing innovative biologics through our protein and screening technology based target discovery platforms.

We are seeking for a scientist with extensive experience in SPR/Biacore technology with profound knowledge and understanding in protein/protein interactions for our Discovery Screening Department.

The position

Lead SPR/Biocore core facility to support DTC unit and Novo Nordisk China R&D site

• Implement SPR and other biophysical technologies to provide affinity, specificity and kinetic data to support target screening, selection, characterization, and validation
• Drive protein/protein interaction based technology development and innovation
• Contribute to global NN projects by working closely with cross functional team members to provide scientific expertise and insights
• Build external visibility by maintaining good publication record and presenting own work at internal and external meetings

Qualifications

Ph.D. in biophysics, biochemistry, protein chemistry, biology or related fields with >2yrs of postdoc training or industrial working experience

• Excellent working knowledge and solid hand-on expertise in using SPR/Biacore or related platforms across a broad range of assays to characterize protein/protein interaction
• Deep understanding of protein/protein interactions as well as proteins and their biochemical and biophysical properties
• Proactive and collaborative to work in a dynamic, innovative, and interdependent research environment
• Excellent oral and written communication skills are essential

Working at Novo Nordisk

At Novo Nordisk, your skills, dedication and ambition help us change lives for the better. In exchange, we offer you an opportunity to work in an international environment with extraordinary talent and benefit from a range of possibilities for professional and personal development.

举报 分享

诺和诺德在中国
诺和诺德是中国市场的领导者，一直以改变为己任。诺和诺德（中国）制药有限公司于1994年成立，二十几年来业务一直保持强劲增长。公司总部设在北京，产品和服务遍及全国所有省、直辖市及中国港澳台地区。截至2017年底，诺和诺德在华员工总数4329人。诺和诺德是在中国建立研发中心的生物制药公司。位于北京的研发中心是诺和诺德全球研发体系的组成部分，致力于与总部合作研发新产品及新生产工艺。诺和诺德在中国的生产厂位于天津，是公司的国际化战略生产基地。公司对工厂提供了大量的资金投入和技术支持，向全球以及中国市场供应产品。诺和诺德在中国的不断发展反映了公司对中国市场的承诺。

Novo Nordisk in China
As the leader in the Chinese market, Novo Nordisk has always been committed to Changing.
Founded in 1994 and headquartered in Beijing, Novo Nordisk’s presence in China has been growing for more than 20 years.Headquartered in Beijing, providing products and services across mainland China as well as Hong Kong, Macau and Taiwan of China. As of the end of 2017, Novo Nordisk employed over 4,329 employees in China.